KRChoksey research report on Colgate PalmoliveColgate Palmolive Ltd has maintained its leadership position in the oral care segment and is one of the most trusted brands in the markets. Focus always remains to create new segments through innovation and technology, driving efficiency with cost reduction in core category with continued commitment of growth. We believe that Colgate at CMP INR 974, the stock is trading at 41.5x FY16E & 36.1x FY17E. We recommend a “ACCUMULATE” on the stock with a target of INR 1107 with a potential upside of 13.7%.Sales stood at INR 10384.7 Mn which grew by 4% y-o-y and 3% q-o-q out of which volume growth was about 3%. EBIDTA stood at INR 2549.1 Mn with 24.5% margin. Growth in EBITDA is about 36% y-o-y and 26% q-o-q and with growth of 588bps y-o-y and 457 bps q-o-q due to lower employee and advertisement expense. PAT stood at INR 1569.3 Mn and margin was at 15.1%. PAT saw growth of 33% y-o-y and 55% q-o-q with change of 213 bps y-o-y and 380bps q-o-q.For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!